Day 3 May 31(Sat)
09:00-10:10 |
Oral Presentation 3
Room 1
|
- Chair(s)
-
Dong Jin Chung (Chonnam National University, Korea), Hyuntae Park (Dong-A University, Korea)
Day 3 May 31(Sat)
09:00-10:10 |
Oral Presentation 4
Room 2
|
- Chair(s)
-
Je-Yong Choi (Kyungpook National University, Korea), Serk In Park (Korea University, Korea)
Day 3 May 31(Sat)
09:00-09:50 |
Meet the Expert 3
Room 3
|
09:00-09:50 |
Vertebral Fracture Recognition for Non-Radiologists
William D. Leslie (University of Manitoba, Canada) |
Day 3 May 31(Sat)
10:15-11:05 |
Plenary Lecture 3
Room 1
|
Emerging evidence indicates that the cells of skeletal system demand large amount of energy for the development and function. The understanding of integrated mechanisms of energy metabolism and bone cells has been greatly enhanced by combined approaches using sophisticated modern analytical tools that enable the quantification of metabolic intermediates and advanced mouse genetic approaches that allow investigation into diverse molecular mechanisms. Dr. Thomas Clemens’ research is focused on the identification of cellular and molecular mechanisms by which osteoblast differentiation and activities are regulated and integrated with energy metabolism and homeostasis. In the current session, Dr. Clemens will discuss historical and contemporary studies that expands our knowledge of the metabolic properties of osteoblasts and their complex interactions with the metabolic and endocrine networks of the body. These novel insights will contribute to better understand the skeletal bioenergetics and its physiological significance in human health and diseases, especially in face of the increasing prevalence of diabetes and other metabolic disorders worldwide.
- Chair(s)
-
Deog Yoon Kim (Kyung Hee University, Korea)
10:15-11:05 |
Osteoblast Bioenergetics and Skeletal Energy Metabolism
Thomas L. Clemens (University of Maryland, USA) |
Day 3 May 31(Sat)
11:20-12:35 |
Symposium 4. Rare Bone Diseases: Unraveling Challenges and Advancing Solutions
Room 1
|
Rare Bone Diseases (RBD) represent a particularly challenging area in diagnosis and treatment. Without timely detection and proper management, patients can endure significant suffering and long-term complications. This symposium will provide an in-depth exploration of the pathophysiology and advanced therapeutic approaches for RBDs, with distinguished experts from around the world sharing their insights and experiences. The first lecture, From Pathophysiology to Treatment: Burosumab in XLH Management, will delve into the pathophysiology of X-linked hypophosphatemia (XLH) and introduce the latest therapeutic strategies using Burosumab. The second lecture, Get Straight to the Source of Hypophosphatasia, will discuss the root causes of hypophosphatasia and share the latest treatment advancements targeting this condition. The final lecture, Rare Bone Diseases in Korea: Current Challenges and Future Directions, will analyze the challenges faced by patients with rare bone diseases in Korea and propose future solutions. Rare bone diseases have a profound impact on patients’ lives, yet they are often overlooked. This session aims to raise awareness of these conditions and provide valuable opportunities to improve the diagnosis and care of RBD patients.
- Chair(s)
-
Young-Joo Kwon (Korea University, Korea), Ha Young Kim (University of Ulsan, Korea)
11:20-11:45 |
New Horizons in XLH Management: Burosumab and Beyond
Adalbert Raimann (Medical University of Vienna, Austria) |
11:45-12:10 |
Get Straight to the Source of Hypophosphatasia
Eric Rush (Children's Mercy Kansas City, USA) |
12:10-12:35 |
Rare Bone Disease in Korea: Current Challenges and Future Directions
Yumie Rhee (Yonsei University, Korea) |
Day 3 May 31(Sat)
11:20-12:35 |
Symposium 5. KSBMR-KCR Joint Symposium: Osteoimmunology
Room 2
|
Osteoimmunology is a field that studies the complex interactions between the skeletal and immune systems, playing a crucial role in understanding the pathogenesis of various bone and immune-related diseases. The signaling processes between immune cells and bone cells regulate bone formation and resorption, with inflammatory cytokines and immune regulatory factors playing essential roles in these processes. Recent studies indicate that changes in the immune system are closely linked to the progression of diseases such as osteoporosis, rheumatoid arthritis, and osteoarthritis, leading to the development of novel therapeutic strategies. In particular, active research is being conducted on the regulatory mechanisms of macrophages and osteoclasts, the relationship between circadian rhythms and bone metabolism, and the impact of inflammatory responses on bone loss.
This KSBMR-KCR Joint Symposium will introduce the latest research in the field of osteoimmunology, focusing on the mechanisms by which macrophage-derived osteoclasts regulate the balance between bone resorption and formation and their role in inflammatory arthritis. Additionally, the symposium will comprehensively examine the importance of maintaining osteoimmune homeostasis based on the interaction between immune responses and bone metabolism. Furthermore, it will analyze the effects of immune cells and circadian rhythm changes on cartilage and bone tissue, proposing therapeutic strategies for bone diseases. These studies provide critical foundational knowledge for developing immune regulation-based treatments for refractory bone diseases, demonstrating the essential role of osteoimmune approaches in the future treatment of bone metabolic diseases. Moreover, by integrating research in bone metabolism and immunology, this symposium aims to deepen the understanding of the pathological mechanisms of bone diseases and propose new directions for osteoimmune-based therapeutic development.
- Chair(s)
-
Chan Soo Shin (Seoul National University, Korea), Seung Cheol Shim (Chungnam National University, Korea)
11:20-11:45 |
Macrophages in the Regulation of Osteoimmune Homeostasis
Eun-Ju Chang (University of Ulsan, Korea) |
11:45-12:10 |
Peripheral Circadian Rhythm Disruption as a Potential Driver of Age-Related ECM Destruction in Osteoarthritis
Je-Hwang Ryu (Chonnam National University, Korea) |
12:10-12:35 |
Molecular and Cellular Basis of Joint Destruction in Rheumatoid Arthritis
Seungwoo Han (Kyungpook National University, Korea) |
Day 3 May 31(Sat)
11:20-12:35 |
Working Group 3. Fracture Working Group
K
The Update of Treatment of Osteoporotic Fractures
Room 3
|
- Chair(s)
-
Jae-Hwi Nho (Soonchunhyang University, Korea)
11:20-11:45 |
The Update of Treatment of Osteoporotic Vertebral Fractures
Joonghyun Ahn (The Catholic University of Korea, Korea) |
11:45-12:10 |
The Update of Treatment of Osteoporotic Hip Fractures
Se-Won Lee (The Catholic University of Korea, Korea) |
12:10-12:35 |
The Update of Treatment of Osteoporotic Knee Fracture
Dong-Geun Kang (Yeson Hospital, Korea) |
Day 3 May 31(Sat)
12:35-12:50 |
Luncheon Symposium 3
Room 1
|
- Chair(s)
-
Keeho Song (Konkuk University, Korea)
12:35-12:50 |
TBD
TBD (TBD) |
Day 3 May 31(Sat)
12:35-12:50 |
Luncheon Symposium 4
Room 2
|
- Chair(s)
-
Tae-Young Kim (Konkuk University, Korea)
12:35-12:50 |
TBD
TBD (TBD) |
Day 3 May 31(Sat)
13:35-14:45 |
Oral Presentation 5
Room 1
|
- Chair(s)
-
Gun-Il Im (Dongguk University, Korea), Yoon-Kyoung Sung (Hanyang University, Korea)
Day 3 May 31(Sat)
13:35-14:45 |
Oral Presentation 6
Room 2
|
- Chair(s)
-
Hong-Hee Kim (Seoul National University, Korea), Seoung Hoon Lee (Wonkwang University, Korea)
Day 3 May 31(Sat)
13:35-14:25 |
Meet the Expert 4
Room 3
|
13:35-14:25 |
Evidence for a Bone-Brain Connection
Theresa A. Guise (The University of Texas MD Anderson Cancer Center, USA) |
Day 3 May 31(Sat)
15:00-16:15 |
Symposium 6. The Next Frontier in Bone Health: Exploring Anabolic Strategies Across Contexts
Room 1
|
Anabolic therapies represent a groundbreaking paradigm in osteoporosis treatment by promoting bone formation, distinguishing themselves from traditional therapeutic approaches. This symposium will comprehensively explore the latest knowledge and clinical applications of anabolic therapies. The first lecture, Effects of Anabolics on Bone: Bridging the Gap Between Clinical Trials and Real-World Practice, will compare outcomes from clinical trials with real-world practice and discuss appropriate therapeutic strategies for effective implementation. The second lecture, Transforming Fracture Care: Paradigm Shifts with Anabolic Therapies, will focus on how anabolic therapies are driving paradigm shifts in fracture care, offering innovative approaches for treatment. The final lecture, Anabolics in Cancer Patients: To Use or Not to Use?, will analyze the potential benefits and risks of using anabolic therapies in cancer patients, exploring their feasibility in this unique population. This session aims to re-evaluate the potential of anabolic therapies and provide valuable insights into optimizing their use in clinical practice to achieve better patient outcomes.
- Chair(s)
-
Kyuri Hwang (Seoul National University, Korea), Seung-Hoon Baek (Kyungpook National University, Korea)
15:00-15:25 |
Effects of Anabolics on Bone: Bridging the Gap between Clinical Trials and Real-World Practice
Ha Young Kim (University of Ulsan, Korea) |
15:25-15:50 |
Transforming Fracture Care: Paradigm Shifts with Anabolic Therapies
Jae Hyuk Yang (Korea University, Korea) |
15:50-16:15 |
Anabolics in Cancer Patients: To Use or Not to Use?
A Ram Hong (Chonnam National University, Korea) |
Day 3 May 31(Sat)
15:00-16:15 |
Symposium 7. Rewiring Muscle Biology: From Stem Cells to Therapeutic Innovations
Room 2
|
- Chair(s)
-
Yun-Sil Lee (Seoul National University, Korea), Dongryeol Ryu (GIST, Korea)
15:00-15:25 |
Circulating Pro-Aging Factors in Sarcopenia: Biomarker Potential and Therapeutic Perspective
Beom-Jun Kim (University of Ulsan, Korea) |
15:25-15:50 |
The Aging Body Plan
Miguel A. Esteban (Chinese Academy of Sciences, China) |
15:50-16:15 |
Thermogenesis in Muscle and Brown Fat
Xingxing Kong (Fudan University, China) |
Day 3 May 31(Sat)
15:00-16:15 |
Working Group 4. Dental and Craniofacial Working Group
K
Updated Position of MRONJ, Dental Perspectives
Room 3
|
- Chair(s)
-
Yong-Dae Kwon (Kyung Hee University, Korea)
15:00-15:25 |
Recent Update of Local Risk Factors for MRONJ
Jae-Young Kim (Yonsei University, Korea) |
15:25-15:50 |
Adjunctive Therapies and Risk-Minimizing Surgical Strategies in MRONJ Management
Moon-Young Kim (Dankook University, Korea) |
15:50-16:15 |
Management of Recurrent MRONJ and Resuming Antiresorptive Therapy
Jun-Young Kim (Yonsei University, Korea) |